Literature DB >> 18755053

DNA topoisomerases: harnessing and constraining energy to govern chromosome topology.

Allyn J Schoeffler1, James M Berger.   

Abstract

DNA topoisomerases are a diverse set of essential enzymes responsible for maintaining chromosomes in an appropriate topological state. Although they vary considerably in structure and mechanism, the partnership between topoisomerases and DNA has engendered commonalities in how these enzymes engage nucleic acid substrates and control DNA strand manipulations. All topoisomerases can harness the free energy stored in supercoiled DNA to drive their reactions; some further use the energy of ATP to alter the topology of DNA away from an enzyme-free equilibrium ground state. In the cell, topoisomerases regulate DNA supercoiling and unlink tangled nucleic acid strands to actively maintain chromosomes in a topological state commensurate with particular replicative and transcriptional needs. To carry out these reactions, topoisomerases rely on dynamic macromolecular contacts that alternate between associated and dissociated states throughout the catalytic cycle. In this review, we describe how structural and biochemical studies have furthered our understanding of DNA topoisomerases, with an emphasis on how these complex molecular machines use interfacial interactions to harness and constrain the energy required to manage DNA topology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755053     DOI: 10.1017/S003358350800468X

Source DB:  PubMed          Journal:  Q Rev Biophys        ISSN: 0033-5835            Impact factor:   5.318


  208 in total

1.  The tyrosyl-DNA phosphodiesterase gene family in Medicago truncatula Gaertn.: bioinformatic investigation and expression profiles in response to copper- and PEG-mediated stress.

Authors:  Anca Macovei; Alma Balestrazzi; Massimo Confalonieri; Daniela Carbonera
Journal:  Planta       Date:  2010-05-11       Impact factor: 4.116

Review 2.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

3.  A mechanism for the evolution of phosphorylation sites.

Authors:  Samuel M Pearlman; Zach Serber; James E Ferrell
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

4.  Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.

Authors:  Katie J Aldred; Sylvia A McPherson; Pengfei Wang; Robert J Kerns; David E Graves; Charles L Turnbough; Neil Osheroff
Journal:  Biochemistry       Date:  2011-12-16       Impact factor: 3.162

5.  Purification, crystallization and preliminary X-ray crystallographic studies of the Mycobacterium tuberculosis DNA gyrase CTD.

Authors:  Amélie Darmon; Jérémie Piton; Mélanie Roué; Stéphanie Petrella; Alexandra Aubry; Claudine Mayer
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-01-26

6.  Unlinking of supercoiled DNA catenanes by type IIA topoisomerases.

Authors:  Alexander Vologodskii
Journal:  Biophys J       Date:  2011-09-20       Impact factor: 4.033

7.  Probing conformational changes in human DNA topoisomerase IIα by pulsed alkylation mass spectrometry.

Authors:  Yu-Tsung Chen; Tammy R L Collins; Ziqiang Guan; Vincent B Chen; Tao-Shih Hsieh
Journal:  J Biol Chem       Date:  2012-06-07       Impact factor: 5.157

8.  Synergic and opposing activities of thermophilic RecQ-like helicase and topoisomerase 3 proteins in Holliday junction processing and replication fork stabilization.

Authors:  Anna Valenti; Mariarita De Felice; Giuseppe Perugino; Anna Bizard; Marc Nadal; Mosè Rossi; Maria Ciaramella
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

9.  Free energy calculations reveal rotating-ratchet mechanism for DNA supercoil relaxation by topoisomerase IB and its inhibition.

Authors:  Jeff Wereszczynski; Ioan Andricioaei
Journal:  Biophys J       Date:  2010-08-04       Impact factor: 4.033

10.  Type IIA topoisomerase inhibition by a new class of antibacterial agents.

Authors:  Benjamin D Bax; Pan F Chan; Drake S Eggleston; Andrew Fosberry; Daniel R Gentry; Fabrice Gorrec; Ilaria Giordano; Michael M Hann; Alan Hennessy; Martin Hibbs; Jianzhong Huang; Emma Jones; Jo Jones; Kristin Koretke Brown; Ceri J Lewis; Earl W May; Martin R Saunders; Onkar Singh; Claus E Spitzfaden; Carol Shen; Anthony Shillings; Andrew J Theobald; Alexandre Wohlkonig; Neil D Pearson; Michael N Gwynn
Journal:  Nature       Date:  2010-08-04       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.